Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Altered Angiogenic Gene Expression Profiles in Porcine Von Willebrand Disease

Mario von Depka, MD PhD, Katharina Kaiser, Carsten Detering, MSc, Mahnaz Ekhlasi-Hundrieser, PhD, Christiane Pfarrer, DVM, Prof, Stefanie Lehner, DVM, PhD

Blood (2019) 134 (Supplement_1): 4917.

https://doi.org/10.1182/blood-2019-122407

Published: 2019

Journal Articles

Expression Profile of VEGF and VEGFR2 in the Female Reproductive Tract at the Time of Placentation in a Porcine Model of Von Willebrand Disease Type 1

Mario von Depka, MD PhD, Mahnaz Ekhlasi-Hundrieser, Carsten Detering, MSc, Stefanie Lehner, Christiane Pfarrer, Hanna Allerkamp

Blood (2018) 132 (Supplement 1): 3776.

https://doi.org/10.1182/blood-2018-99-112085

Published: 2018

Journal Articles

Immunohistochemical Analyses and Quantitative RT-PCR of Angiogenic Factors in a Porcine Von Willebrand Disease Model

Mario Von Depka, MD PhD, Hanna Allerkamp, Mahnaz Ekhlasi-Hundrieser, Christiane Pfarrer, Carsten Detering, MSc, Stefanie Lehner

Blood (2017) 130 (Supplement 1): 1074.

https://doi.org/10.1182/blood.V130.Suppl_1.1074.1074

Published: 2017

Journal Articles

Observational Study on Safety and Efficacy of Factor Replacement Therapy in the Management of Von Willebrand Disease Patients - Results from an Ongoing Study with a VWF/FVIII Concentrate

Hassan M. Yaish, Kate Khair, Mario von Depka, Maria Sol Cruz, Sylvia Werner, Sigurd Knaub, George M. Rodgers

Blood (2016) 128 (22): 4968.

https://doi.org/10.1182/blood.V128.22.4968.4968

Published: 2016

Journal Articles

Immunohistochemical Analyses on Angiogenesis in a Porcine Von Willebrand Disease Model

Mario Von Depka, Hanna Allerkamp, DVM, Mahnaz Ekhlasi-Hundrieser, PhD, Christiane Pfarrer, Prof. DVM, Carsten Detering, MSc, Stefanie Lehner, DVM, PhD

Blood (2016) 128 (22): 2564.

https://doi.org/10.1182/blood.V128.22.2564.2564

Published: 2016

Journal Articles

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

Elena Santagostino, Uri Martinowitz, Toshko Lissitchkov, Brigitte Pan-Petesch, Hideji Hanabusa, Johannes Oldenburg, Lisa Boggio, Claude Negrier, Ingrid Pabinger, Mario von Depka Prondzinski, Carmen Altisent, Giancarlo Castaman, Koji Yamamoto, Maria-Teresa Álvarez-Roman, Christine Voigt, Nicole Blackman, Iris Jacobs

Blood (2016) 127 (14): 1761–1769.

https://doi.org/10.1182/blood-2015-09-669234

Published: 2016

Includes: Supplemental data

Journal Articles

Management of Perioperative Anticoagulation in Patients with VWD

Mario Von Depka, MD PhD, Carsten Detering, MSc, Stefanie Döpke, Mahnaz Ekhlasi-Hundrieser, PhD

Blood (2015) 126 (23): 1100.

https://doi.org/10.1182/blood.V126.23.1100.1100

Published: 2015

Journal Articles

Phenotypic and Genotypic Correlations in 218 Patients with VWD Including Platelet Function

Mario von Depka, MDPhD, Carsten Detering, MSc, Christiane Halves, Mahnaz Ekhlasi-Hundrieser, PhD

Blood (2014) 124 (21): 2834.

https://doi.org/10.1182/blood.V124.21.2834.2834

Published: 2014

Journal Articles

Final Evaluation Of a Prospective, Non-Interventional Study On Efficacy and Tolerability Of a New Generation VWF/FVIII Concentrate In The Treatment Of Von Willebrand Disease

Sonja Alesci, MD, Mario Von Depka, Jennifer Feddern, Susan Halimeh, MD, Oliver Hegener, PhD, Janos Kadar, Wolfgang A. Miesbach, MD, PhD, Ulrike Nowak-Göttl, Inge Scharrer, MD, PhD

Blood (2013) 122 (21): 4775.

https://doi.org/10.1182/blood.V122.21.4775.4775

Published: 2013

Journal Articles

Management Of Pregnancy In Patients With Antithrombin Deficiency

Mario von Depka, MD PhD, Stefanie Döpke, Anja Henkel-Klene, MD, Cornelia Wermes, MD, Mahnaz Ekhlasi-Hundrieser, PhD, Carsten Detering

Blood (2013) 122 (21): 216.

https://doi.org/10.1182/blood.V122.21.216.216

Published: 2013

Journal Articles

Descriptive Evaluation of Age-Related Differences in Clinical Manifestation and Treatment of Von Willebrand's Disease in an Open-Label, Prospective, Non-Interventional Study (wilate ® -SET)

Oliver Hegener, PhD, Inge Scharrer, MD, PhD, Jennifer Feddern, Wolfgang A. Miesbach V, MD, PhD, Mario Von Depka, Janos Kadar

Blood (2012) 120 (21): 4630.

https://doi.org/10.1182/blood.V120.21.4630.4630

Published: 2012

Journal Articles

Human-Cl Rhfviii Effectively and Safely Prevents Bleeding Episodes in Previously Treated Adult Patients with Severe Haemophilia A

Sigurd Knaub, PhD, Toshko Lissitchkov, MD, PhD, Kingsley Hampton, Mario Von Depka, Savita Rangarajan, MBBS, FRCP, FRCPath, Charles R.M. Hay, MD, FRCP, FRCPath, Edward GD Tuddenham, MBBS, FRCP, FRCPath, PhD, Peter Collins, MD, Katharina Holstein, MD, Angela Huth-Kühne, Ingrid Pabinger, MD, Johannes Oldenburg, MD, Johann Bichler

Blood (2012) 120 (21): 1132.

https://doi.org/10.1182/blood.V120.21.1132.1132

Published: 2012

Journal Articles

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

Blood (2012) 120 (18): 3670–3676.

https://doi.org/10.1182/blood-2012-06-438804

Published: 2012

Journal Articles

Final Results From a Phase II Trial with the First in Class Recombinant Polyclonal Antibody Product Rozrolimupab in Primary Immune Thrombocytopenia

Blood (2011) 118 (21): 527.

https://doi.org/10.1182/blood.V118.21.527.527

Published: 2011

Journal Articles

Acquired Hemophilia Caused by Non-Hemophilic Factor VIII Gene Variants.

Andreas Tiede, MD, PhD, Roswith Eisert, MD, Andreas Czwalinna, PhD, Wolfgang Miesbach, MD, Inge Scharrer, MD, Arnold Ganser, MD, Mario von Depka, MD

Blood (2004) 104 (11): 3083.

https://doi.org/10.1182/blood.V104.11.3083.3083

Published: 2004

Journal Articles

Activated Recombinant Factor VII (rFVIIa/NovoSeven®) in the Treatment of Bleeding Complications Following Hematopoietic Stem Cell Transplantation (HSCT).

Benjamin Brenner, Markus Pihusch, Andrea Bacigalupo, Jeff Szer, Mario von Depka Prondzinski, Bettina Gaspar-Blaudschun, Liselotte Hyveled

Blood (2004) 104 (11): 1135.

https://doi.org/10.1182/blood.V104.11.1135.1135

Published: 2004

Journal Articles

Safety and Efficacy of Prophylactic Intravenous Administration of Recombinant Human Antithrombin (rhAT) to Hereditary AT Deficient Patients in High-Risk Situations.

Mario von Depka, MD, PhD, Don Shaffer, MD, Francesco Baudo, MD, Caroline Shiach, MD, Johan Frieling, MD, PhD, Judith Bonfiglio, BSN, CRNA, the GTC rHAT Study Group

Blood (2004) 104 (11): 4076.

https://doi.org/10.1182/blood.V104.11.4076.4076

Published: 2004

Journal Articles

Thromboelastometry in Patients Receiving Platelet Transfusion after Chemotherapy.

Henning Dehmel, Andreas Tiede, MD, PhD, Silvia Horter, Arnold Ganser, MD, Mario von Depka, MD

Blood (2004) 104 (11): 3630.

https://doi.org/10.1182/blood.V104.11.3630.3630

Published: 2004

Journal Articles

Hemostatic Alterations in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Stefanie Buchholz, MD, Alexander Woywodt, MD, Johanna Scheer, Lothar Hambach, MD, Haytham Kamal, Hermann Haller, MD, Marion Haubitz, MD, Arnold Ganser, MD, Bernd Hertenstein, MD, Mario von Depka, MD

Blood (2004) 104 (11): 985.

https://doi.org/10.1182/blood.V104.11.985.985

Published: 2004

Journal Articles

Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism

Mario von Depka, Ulrike Nowak-Göttl, Roswith Eisert, Christian Dieterich, Monika Barthels, Inge Scharrer, Arnold Ganser, Silke Ehrenforth

Blood (2000) 96 (10): 3364–3368.

https://doi.org/10.1182/blood.V96.10.3364

Published: 2000

NARROW

Altered Angiogenic Gene Expression Profiles in Porcine Von Willebrand Disease

Expression Profile of VEGF and VEGFR2 in the Female Reproductive Tract at the Time of Placentation in a Porcine Model of Von Willebrand Disease Type 1

Immunohistochemical Analyses and Quantitative RT-PCR of Angiogenic Factors in a Porcine Von Willebrand Disease Model

Observational Study on Safety and Efficacy of Factor Replacement Therapy in the Management of Von Willebrand Disease Patients - Results from an Ongoing Study with a VWF/FVIII Concentrate

Immunohistochemical Analyses on Angiogenesis in a Porcine Von Willebrand Disease Model

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

Management of Perioperative Anticoagulation in Patients with VWD

Phenotypic and Genotypic Correlations in 218 Patients with VWD Including Platelet Function

Final Evaluation Of a Prospective, Non-Interventional Study On Efficacy and Tolerability Of a New Generation VWF/FVIII Concentrate In The Treatment Of Von Willebrand Disease

Management Of Pregnancy In Patients With Antithrombin Deficiency

Descriptive Evaluation of Age-Related Differences in Clinical Manifestation and Treatment of Von Willebrand's Disease in an Open-Label, Prospective, Non-Interventional Study (wilate ® -SET)

Human-Cl Rhfviii Effectively and Safely Prevents Bleeding Episodes in Previously Treated Adult Patients with Severe Haemophilia A

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

Final Results From a Phase II Trial with the First in Class Recombinant Polyclonal Antibody Product Rozrolimupab in Primary Immune Thrombocytopenia

Acquired Hemophilia Caused by Non-Hemophilic Factor VIII Gene Variants.

Activated Recombinant Factor VII (rFVIIa/NovoSeven®) in the Treatment of Bleeding Complications Following Hematopoietic Stem Cell Transplantation (HSCT).

Safety and Efficacy of Prophylactic Intravenous Administration of Recombinant Human Antithrombin (rhAT) to Hereditary AT Deficient Patients in High-Risk Situations.

Thromboelastometry in Patients Receiving Platelet Transfusion after Chemotherapy.

Hemostatic Alterations in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only